Table 2.
Clinical characteristics of 356 cancer patients recruited in the first phase of the LACAM study.
| Clinical Characteristics (N = 356) | ||
|---|---|---|
| N | % | |
| PRIMARY CANCER SITE | ||
| Breast | 268 | 75.3 |
| Ovary | 75 | 21.1 |
| Multiple primaries (*) | 4 | 1.1 |
| Missing | 9 | 2.5 |
| HISTOPATHOLOGICAL SUBTYPE BREAST CANCER | ||
| DCIS | 1 | 0.4 |
| IDC | 173 | 64.5 |
| ILC | 13 | 4.9 |
| MC | 1 | 0.4 |
| TN | 8 | 3.0 |
| Missing | 72 | 26.9 |
| HISTOPATHOLOGICAL SUBTYPE OVARIAN CANCER | ||
| SC | 46 | 61.3 |
| EC | 5 | 6.7 |
| CCC | 3 | 4.0 |
| Missing | 21 | 28.0 |
| STAGE AT DIAGNOSIS | ||
| I | 25 | 7.0 |
| II | 53 | 14.9 |
| III | 68 | 19.1 |
| IV | 4 | 1.1 |
| No Information | 206 | 57.9 |
DCIS, Ductal carcinoma in situ; IDC, Invasive ductal carcinoma; ILC, Invasive lobular carcinoma; MC, Medullary carcinoma; TN, Triple negative; SC, Serous carcinoma; EC, Endometrioid carcinoma; CCC, Clear cell carcinoma. (*) Breast, Colon, Thyroid, Pancreas, Endometrial.